Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 6/20 | 0.56 |
| ▸ | MDM4 | O15151 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 3/20 | 0.56 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.47 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 2/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27393601 | 1.00 | MDM2 (0.56) | MDM2MDM4TP53PIN1SLC17A5 | |
| SCHEMBL29634850 | 0.90 | MDM2 (0.60) | MDM2MDM4TP53PIN1SLC17A5 | |
| SCHEMBL22636173 | 0.90 | MDM2 (0.60) | MDM2MDM4TP53PIN1SLC17A5 | |
| SCHEMBL22636171 | 0.90 | MDM2 (0.60) | MDM2MDM4TP53PIN1SLC17A5 | |
| SCHEMBL29855146 | 0.90 | MDM2 (0.60) | MDM2MDM4TP53PIN1SLC17A5 | |
| SCHEMBL30951921 | 0.90 | MDM4 (0.51) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL30951908 | 0.90 | MDM4 (0.51) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL30951920 | 0.90 | MDM4 (0.51) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL25178646 | 0.88 | MDM2 (0.51) | MDM2MDM4TP53SLC17A5CASP3 | |
| SCHEMBL25178647 | 0.88 | MDM2 (0.51) | MDM2MDM4TP53SLC17A5CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4605409-A2 | CYCLIN INHIBITORS | Circle Pharma, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| WO-2024086814-A2 | CYCLIN INHIBITORS | CIRCLE PHARMA, INC. (US) | 2024-04-25 | — | — | WO | disclosed |